News

Intravenous Administration of Atorvastatin Protects Against Infarction in the Presence of Diabetic Cardiomyopathy

Intravenous administration of atorvastatin during acute myocardial infarction could become a new therapeutic strategy capable of limiting infarct size in patients with diabetic cardiomyopathy, a heart...

IR Sant Pau Strengthens Collaboration with Ephion Health and Joins the Startup’s Shareholding

The Sant Pau Research Institute (IR Sant Pau) has formalized a strategic agreement with Ephion Health, a company specialized in developing artificial intelligence technologies for monitoring mobility ...

Over €100,000 raised for Ewing Sarcoma research at Sant Pau

In November 2023, the charity race L’Arriarem, organized by the family of Marc Riera i Castellà in his memory, raised over €96,000. Thanks to this momentum and all subsequent donations, €101,33...

A New CAR-T Therapy from Sant Pau Achieves Positive Results in a High Proportion of Patients with a Refractory Type of Lymphoma

Researchers at the Sant Pau Research Institute (IR Sant Pau), in collaboration with the Hospital de Sant Pau and the Josep Carreras Leukaemia Research Institute, have developed an innovative CAR-T cel...

Sant Pau Celebrates the Recognition of Dr. Montserrat Baiget with the Creu de Sant Jordi

The Sant Pau Research Institute (IR Sant Pau) expresses its great satisfaction and pride in the awarding of the Creu de Sant Jordi to Dr. Montserrat Baiget—an honor granted by the Government of Cata...